# Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)

> **NCT07628972** · PHASE1 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 12 (estimated)

## Conditions studied

- Dyskeratosis Congenita
- Telomere Disease

## Interventions

- **DRUG:** Quercetin

## Key facts

- **NCT ID:** NCT07628972
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-29
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628972, "Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07628972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*